Eptifibatide-induced acute profound thrombocytopenia: A case report

Eptifibatide-induced acute profound thrombocytopenia: A case report

<h3>Rationale</h3><p dir="ltr">Eptifibatide is an antiplatelet agent used in the medical management of acute coronary syndrome. Although multiple studies did not reveal a significant association between eptifibatide and the development of thrombocytopenia, recent case rep...

Full description

Saved in:
Bibliographic Details
Main Author: Mohammed A. Alamin (14182297) (author)
Other Authors: Abdulrahman Al-Mashdali (16388474) (author), Dawoud I. Al Kindi (17191426) (author), Elkhansa A. Elshaikh (21348560) (author), Fahmi Othman (14777506) (author)
Published: 2022
Subjects:
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Pharmacology and pharmaceutical sciences
acute coronary syndrome
drug-induced thrombocytopenia
eptifibatide
glycoprotein IIa/IIIb inhibitors
thrombocytopenia
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items